This article is supported by a grant from the Okyanos Heart Institute, Freeport, The
Bahamas.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans.Circulation. 2002; 106: 1913-1918
- Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure.Circulation. 2003; 107: 2294-2302
- Stem Cell Therapy to Treat Heart Failure.in: 2nd ed. Elsevier, New York2011: 407-423
- 10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart.J Am Coll Cardiol. 2011; 58: 1095-1104
- Cell therapy for heart disease. Where are we in 2011?.J Am Coll Cardiol. 2011; 57: 466-468
- The tumorigenicity of human embryonic stem cells.Adv Cancer Res. 2008; 100: 133-158
- Human mesenchymal stem cells moderate allogenic immune cell responses.Blood. 2005; 105: 1815-1822
- Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial.Lancet. 2012; 379: 895-904
- Human cardiospheres are a source of stem cells with cardiomyogenic potential.Stem Cells. 2010; 28: 903-904
- Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomized phase 1 trial.Lancet. 2011; 378: 1847-1857
- Myocardin-related transcription factor-A controls myofibroblast activation and fibrosis in response to myocardial infarction.Circ Res. 2010; 107: 294-304
- Adult cardiac stem cells are multipotent and support myocardial regeneration.Cell. 2003; 114: 763-776
- Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy.Lancet. 2003; 362: 697-703
- Lack of benefit from percutaneous intervention of persistently occluded infarct arteries after the acute phase of myocardial infarction is time independent: insights from Occluded Artery Trial.Eur Heart J. 2009; 30: 183-191
- Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial.JAMA. 2012; 307: 1717-1726
- Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial.JAMA. 2012; 307: 1169-1177
- Statins enhance clonal growth of late outgrowth endothelial progenitors and increase myocardial capillary density in the chronically ischemic heart.PLoS One. 2011; 6: e24868
- Stem cell therapy for heart failure.Circulation. 2009; 119: 2735-2740
- A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction.J Am Coll Cardiol. 2009; 54: 2277-2286
- More “malignant” than cancer?.Eur Heart Fail. 2001; 3: 315-322
Article Info
Publication History
Published online: July 23, 2012
Footnotes
This article is based on a discussion among the faculty on March 26, 2012 (Chicago, Illinois).
Identification
Copyright
© 2012 Elsevier Inc. Published by Elsevier Inc. All rights reserved.